rs202194703

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_000719.7(CACNA1C):​c.4641C>T​(p.Asn1547Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,613,972 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00030 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.71
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C-AS2 (HGNC:40118): (CACNA1C antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 12-2668950-C-T is Benign according to our data. Variant chr12-2668950-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 93408.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2}.
BP7
Synonymous conserved (PhyloP=1.71 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000302 (46/152320) while in subpopulation AMR AF= 0.000849 (13/15306). AF 95% confidence interval is 0.00058. There are 1 homozygotes in gnomad4. There are 21 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 46 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1CNM_000719.7 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/475 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/471 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.4875C>T p.Asn1625Asn synonymous_variant 40/50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/485 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.4608C>T p.Asn1536Asn synonymous_variant 37/475 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.4806C>T p.Asn1602Asn synonymous_variant 39/48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.4785C>T p.Asn1595Asn synonymous_variant 40/491 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.4707C>T p.Asn1569Asn synonymous_variant 38/471 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/481 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/485 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.4731C>T p.Asn1577Asn synonymous_variant 38/47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.4731C>T p.Asn1577Asn synonymous_variant 38/47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.4731C>T p.Asn1577Asn synonymous_variant 38/47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.4731C>T p.Asn1577Asn synonymous_variant 38/47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.4725C>T p.Asn1575Asn synonymous_variant 39/481 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.4716C>T p.Asn1572Asn synonymous_variant 39/485 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.4701C>T p.Asn1567Asn synonymous_variant 39/481 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/471 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/471 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/471 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.4692C>T p.Asn1564Asn synonymous_variant 38/471 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.4683C>T p.Asn1561Asn synonymous_variant 38/47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.4608C>T p.Asn1536Asn synonymous_variant 37/461 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.4608C>T p.Asn1536Asn synonymous_variant 37/461 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.4602C>T p.Asn1534Asn synonymous_variant 37/461 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/471 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/471 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/471 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/471 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.4641C>T p.Asn1547Asn synonymous_variant 38/47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.4632C>T p.Asn1544Asn synonymous_variant 38/47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.4608C>T p.Asn1536Asn synonymous_variant 37/46 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.000302
AC:
46
AN:
152202
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000850
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000598
AC:
15
AN:
250672
Hom.:
0
AF XY:
0.0000295
AC XY:
4
AN XY:
135738
show subpopulations
Gnomad AFR exome
AF:
0.000693
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.000328
GnomAD4 exome
AF:
0.0000233
AC:
34
AN:
1461652
Hom.:
0
Cov.:
30
AF XY:
0.0000193
AC XY:
14
AN XY:
727142
show subpopulations
Gnomad4 AFR exome
AF:
0.000568
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000989
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.000302
AC:
46
AN:
152320
Hom.:
1
Cov.:
32
AF XY:
0.000282
AC XY:
21
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.000794
Gnomad4 AMR
AF:
0.000849
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000986
Hom.:
0
Bravo
AF:
0.000261

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 02, 2013- -
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 14, 2023- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 20, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.23
CADD
Benign
16
DANN
Benign
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs202194703; hg19: chr12-2778116; API